Viewing Study NCT03562832


Ignite Creation Date: 2025-12-24 @ 9:58 PM
Ignite Modification Date: 2025-12-25 @ 7:35 PM
Study NCT ID: NCT03562832
Status: COMPLETED
Last Update Posted: 2025-01-23
First Post: 2018-04-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP
Sponsor: Allarity Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module